JFL Life Sciences
Ticker > Company >

JFL Life Sciences share price

JFL Life Sciences Ltd.

NSE: JFLLIFE SECTOR: Pharmaceuticals & Drugs  28.08 K   13   0

13.65
+0.25 (1.87%)
NSE: 17 Sep 03:41 PM

Price Summary

Today's High

₹ 13.65

Today's Low

₹ 13.65

52 Week High

₹ 37.15

52 Week Low

₹ 12.75

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 45.04 Cr.

Enterprise Value

₹ 50.7 Cr.

No. of Shares

3.3 Cr.

P/E

10.83

P/B

1.12

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  12.18

CASH

₹ 0.03 Cr.

DEBT

₹ 5.69 Cr.

Promoter Holding

67.47 %

EPS (TTM)

₹  1.26

Sales Growth

8.68%

ROE

9.75 %

ROCE

11.46%

Profit Growth

17.74 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.68%
3 Year12.41%
5 Year7.93%

Profit Growth

1 Year17.74%
3 Year82.74%
5 Year61.35%

ROE%

1 Year9.75%
3 Year17.87%
5 Year13.88%

ROCE %

1 Year11.46%
3 Year16.68%
5 Year14.43%

Debt/Equity

0.16

Price to Cash Flow

5.39

Interest Cover Ratio

5.5998

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 67.47 0.00
Mar 2025 67.47 0.00
Sep 2024 67.47 0.00
Mar 2024 67.47 0.00
Sep 2023 67.47 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.610751345060819.
  • Company has a healthy liquidity position with current ratio of 2.1586.
  • The company has a high promoter holding of 67.47%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 25.8513127553506.

 Limitations

  • The company has shown a poor revenue growth of 12.4052548591405% for the Past 3 years.
  • Company has high debtor days of 186.7359.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025
Net Sales 21.25 11.73 11.59
Total Expenditure 19.91 10.36 9.65
Operating Profit 1.34 1.38 1.93
Other Income 0.01 0 0
Interest 0.2 0.33 0.25
Depreciation 0.16 0.36 0.26
Exceptional Items 0 0 0
Profit Before Tax 0.99 0.69 1.43
Tax 0.25 0.61 0.68
Profit After Tax 0.74 0.08 0.75
Adjusted EPS (Rs) 0.22 0.03 0.23

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 30.17 32.77 33.59 42.83 46.55
Total Expenditure 28.31 30.61 28.23 38.9 42
Operating Profit 1.86 2.16 5.36 3.93 4.55
Other Income 0.03 0.09 0.89 1.64 0.52
Interest 1.16 1.23 2.08 1.42 0.83
Depreciation 0.24 0.28 0.37 0.43 0.44
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.5 0.75 3.8 3.72 3.8
Tax 0.14 0.2 0.99 0.91 0.49
Net Profit 0.36 0.54 2.81 2.81 3.31
Adjusted EPS (Rs.) 0.22 0.28 1.17 0.85 1

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.42 0.5 8.02 11 11
Total Reserves 4.95 6.38 3.27 21.27 24.58
Borrowings 1.31 8.18 8.41 1.39 0.98
Other N/C liabilities 0.14 0.19 0.18 0.28 -0.02
Current liabilities 17.5 13.76 28.38 15.12 19.98
Total Liabilities 24.33 29.01 48.26 49.06 56.52
Assets
Net Block 5.05 6.5 7.13 6.8 12.47
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.09 0.14 0.8 0.71 0.51
Other N/C Assets 0.81 1.91 1.03 0.41 0.41
Current Assets 18.37 20.46 39.3 41.14 43.13
Total Assets 24.33 29.01 48.26 49.06 56.52
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.5 0.75 3.8 3.72 3.8
Adjustment 1.33 1.41 2.44 1.85 1.25
Changes in Assets & Liabilities 1.47 -7.93 -4.05 -13.64 3.36
Tax Paid -0.08 -0.09 0.13 -1 -0.06
Operating Cash Flow 3.21 -5.87 2.32 -9.07 8.36
Investing Cash Flow -2.76 -1.64 -0.71 0.87 -6.07
Financing Cash Flow -0.19 7.25 -1.46 8.07 -2.31
Net Cash Flow 0.27 -0.26 0.15 -0.13 -0.03

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Mar 2024% Sep 2024% Mar 2025% Jun 2025%
promoters 67.47 67.47 67.47 67.47 67.47
artiben manishkumar patel... 0.20 0.20 0.20 0.20 0.20
ashokkumar parshottamdas ... 0.27 0.27 0.27 0.27 0.27
ashwinbhai jivrambhai pat... 0.89 0.89 0.89 0.89 0.89
kirtikumar parshottambhai... 0.12 0.12 0.12 0.12 0.12
patel dakshaben - - 0.37 0.37 0.37
rupesh kirtibhai patel 0.34 0.34 0.34 0.34 0.34
shobhnaben kirtikumar pat... 0.18 0.18 0.18 0.18 0.18
smiral ashwinkumar patel 44.33 44.33 44.33 44.33 44.33
smiral ashwinkumar patel ... - - 3.98 3.98 3.98
tejal smiral patel 16.58 16.58 16.58 16.58 16.58
ushaben ashokkumar patel 0.21 0.21 0.21 0.21 0.21
dakshaben patel 0.37 0.37 - - -
smiral ashwinkumar patel ... 3.98 3.98 - - -
PARTICULARS Sep 2022% Mar 2024% Jun 2025%
investors 32.53 32.53 32.53
pratik rajendra gandhi - 1.82 1.22
anuj gupta - 1.15 -
econo broking private lim... 2.62 - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

JFL Life Sciences Stock Price Analysis and Quick Research Report. Is JFL Life Sciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse JFL Life Sciences. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). JFL Life Sciences has a PE ratio of 10.8316140295191 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. JFL Life Sciences has ROA of 6.2663% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. JFL Life Sciences has a Current ratio of 2.1586.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. JFL Life Sciences has a ROE of 9.7516%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. JFL Life Sciences has a Debt to Equity ratio of 0.16 which means that the company has low proportion of debt in its capital.

  • Sales growth: JFL Life Sciences has reported revenue growth of 8.6847% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of JFL Life Sciences for the current financial year is 9.76413543897792%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for JFL Life Sciences is Rs 0.25 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of JFL Life Sciences is Rs 1.2602. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of JFL Life Sciences in Ticker for free. Also, one can get the intrinsic value of JFL Life Sciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

JFL Life Sciences FAQs

Q1. What is JFL Life Sciences share price today?
Ans: The current share price of JFL Life Sciences is Rs 13.65.

Q2. What is the market capitalisation of JFL Life Sciences?
Ans: JFL Life Sciences has a market capitalisation of Rs 45.038615895 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of JFL Life Sciences?
Ans: The PE ratio of JFL Life Sciences is 10.8316140295191 and the P/B ratio of JFL Life Sciences is 1.1203033436746, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of JFL Life Sciences share?
Ans: The 52-week high share price of JFL Life Sciences is Rs 37.15, and the 52-week low share price of JFL Life Sciences is Rs 12.75.

Q5. Does JFL Life Sciences pay dividends?
Ans: Currently, JFL Life Sciences does not pay dividends. Dividend yield of JFL Life Sciences is around 0%.

Q6. What are the face value and book value of JFL Life Sciences shares?
Ans: The face value of JFL Life Sciences shares is Rs 10, while the book value per share of JFL Life Sciences is around Rs 12.1842. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of JFL Life Sciences?
Ans: JFL Life Sciences has a total debt of Rs 5.6923 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of JFL Life Sciences?
Ans: The ROE of JFL Life Sciences is 9.7516% and ROCE of JFL Life Sciences is 11.4627%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is JFL Life Sciences a good buy for the long term?
Ans: The JFL Life Sciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is JFL Life Sciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the JFL Life Sciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check JFL Life Sciences’s financials?
Ans: You can review JFL Life Sciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about JFL Life Sciences
X